Form 8-K - Current report:
SEC Accession No. 0001193125-22-242028
Filing Date
2022-09-09
Accepted
2022-09-09 16:43:04
Documents
15
Period of Report
2022-09-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d359404d8k.htm   iXBRL 8-K 29158
2 EX-1.1 d359404dex11.htm EX-1.1 170659
3 EX-5.1 d359404dex51.htm EX-5.1 9369
7 GRAPHIC g359404img.jpg GRAPHIC 4643
  Complete submission text file 0001193125-22-242028.txt   390736

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA pstv-20220909.xsd EX-101.SCH 2885
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE pstv-20220909_lab.xml EX-101.LAB 17996
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pstv-20220909_pre.xml EX-101.PRE 11281
9 EXTRACTED XBRL INSTANCE DOCUMENT d359404d8k_htm.xml XML 3389
Mailing Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756
Business Address 4200 MARATHON BLVD. SUITE 200 AUSTIN TX 78756 737.255.7194
PLUS THERAPEUTICS, INC. (Filer) CIK: 0001095981 (see all company filings)

EIN.: 330827593 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34375 | Film No.: 221236620
SIC: 3841 Surgical & Medical Instruments & Apparatus